Evidence map›Paper›PMID 41759999›Full record

ReviewMedicine2026

Concomitant immunoglobulin A nephropathy and membranous nephropathy with Fabry-like zebra bodies: A case report and literature review.

Yujie Dai, Chunlei Lu, Guangyu Bi, Gang Zhou, Rong Wang

Abstract readCase ReportsReview
In one paragraph

Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yujie DaiRuikang Clinical Medical College, Affiliated to Guangxi University of Chinese Medicine, Nanning, China.ORCID 0009-0009-2115-9006
Chunlei LuDepartment of Nephrology, Northern Jiangsu People's Hospital, Yangzhou, China.
Guangyu BiDepartment of Nephrology, Northern Jiangsu People's Hospital, Yangzhou, China.
Gang ZhouDepartment of Nephrology, Northern Jiangsu People's Hospital, Yangzhou, China.
Rong WangDepartment of Nephrology, Northern Jiangsu People's Hospital, Yangzhou, China.ORCID 0009-0004-1533-0384

Funding

Hospital Research Projects FCJS202340Hospital Research Projects SBQN22006
6 · The paper itself

Abstract

rationaleImmunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) are common primary glomerular diseases. Although these conditions are well-characterized, their co-occurrence with Fabry-like zebra bodies is exceptionally rare. Fabry-like zebra bodies, characterized pathologically by numerous myeloid bodies within glomerular podocytes, are a hallmark feature of classical Fabry disease. However, similar ultrastructural findings can also arise from other genetic disorders or drug-induced phospholipidosis (e.g., associated with hydroxychloroquine or amiodarone). PATIENT CONCERNS: The patient was a 51-year-old woman with clinical manifestations dominated by massive proteinuria and normal creatinine levels. DIAGNOSES: The patient was diagnosed with IgAN and MN with Fabry-like zebra bodies.

interventionsTreatment comprised angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. OUTCOMES: After 1.5 years, she exhibited considerable decreases in creatinine from 61 μmol/L to 42.9 μmol/L and proteinuria from 3.8 g/24 h to 52.5 mg/24 h. Overall, the patient's clinical course was relatively smooth. Despite transient fluctuations in renal parameters, the patient achieved significant remission of proteinuria and edema following treatment. LESSONS: This case highlights the complexity of diagnosing and managing the co-occurrence of IgAN, MN, and Fabry-like zebra bodies, emphasizing the need for further research on its pathogenesis, treatment, and prognosis.

Indexed as

Fabry DiseaseGlomerulonephritis, IGAGlomerulonephritis, MembranousAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsFemaleHumansMiddle AgedPodocytesProteinuriaAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsFabry diseaseimmunoglobulin A nephropathymembranous nephropathy

Identifiers

PMID41759999
PMCPMC12956247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.